RxDoctor Payments Data

Robert Hendren

Child & Adolescent Psychiatry · San Francisco, CANPI 1639152598

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $1,125 of the $1,163 with a category attached, or 96.7%. Janssen Research & Development, LLC accounts for 96.7% of it on its own, with 1 other manufacturer making up the rest.

$1,163in general payments, 2019–2025

Across 2 payments — averaging $581.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Janssen Research & Development, LLC$1K
  • Genentech, Inc.$38
$484,895in research payments, 2019–2025

Across 129 payments — averaging $3758.88 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Jazz Pharmaceuticals Inc.$169K
  • F. Hoffmann-la Roche AG$163K
  • Otsuka Pharmaceutical Development & Commercialization, Inc.$60K
  • Genentech, Inc.$49K
  • Sunovion Pharmaceuticals Inc.$25K
  • Shire North American Group Inc$19K
  • plus $452 from 1 others

What the payments were for

  • Consulting fees$1,12597%
  • Education$383%

General payments by program year

19
21

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,163 in reported general payments places this provider in the 80th percentile of 434 child & adolescent psychiatry providers in California.

See all child & adolescent psychiatry providers in California

Other child & adolescent psychiatry in San Francisco

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →